Clinical Trials Directory

Trials / Unknown

UnknownNCT01842685

Bladder Thermal Distention for Patients With Refractory Overactive Bladder

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Assaf-Harofeh Medical Center · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this study, the investigators will evaluate the efficacy of Bladder Thermal Distention (BTD) in patients with overactive bladder syndrome who failed previous treatment of anticholinergic drugs. The investigators' hypothesis is that it will improve the storage symptoms.

Detailed description

Inclusion criteria: 1. Patients with overactive bladder syndrome 2. Detrusor Overactivity proven in urodynamic test Exclusion criteria: 1. Mixed urinary incontinence 2. Active urinary tract infection 3. Urethral Stricture Outcome measures: 1. Bladder Diaries 2. Urgency questionnaire

Conditions

Interventions

TypeNameDescription
PROCEDUREBladder Thermal DistentionBladder Thermal Distention is an approved procedure in Europe from 2006. The treatment is hydrodistention of the bladder with a warm saline (up to 45C). The procedure lasts 1 hour. The saline is infused constantly through a 3 ways specific catheter (Unithermia 18F) by the PelvixTT system.

Timeline

Start date
2013-04-01
Primary completion
2014-03-01
Completion
2014-04-01
First posted
2013-04-30
Last updated
2013-04-30

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01842685. Inclusion in this directory is not an endorsement.